- Santa’s Health (Obesity, Soot Wart, Stress and OSA)12:12Living With CFFree Chapter16:02Paperchase #1 - Oxygen Therapy in Suspected Acute Myocardial Infarction5:01Saturday Night Palsy10:33Graves Disease Pt. 111:00Paperchase #2 - Liraglutide and Renal Outcomes in Type 2 Diabetes5:04Stuff that Changed our Practices, Part 110:39Contact Lens Complications21:42Paperchase #3 - Intubated Cardiac Arrest Patients are More Likely to Die5:51HIV Pre-Exposure Prophylaxis22:10Stuff that Changed our Practices, Part 211:00Paperchase #4 - Weight and Metabolic Outcomes 12 Years after Gastric Bypass4:57Common Testicular Problems in Infants14:38Things I Do, But Should I? Symphyseal Fundal Height5:21Paperchase #5 - Don't Bother Rechecking Lipids Once You Start That Statin4:47The Summary18:30
The Objective of this study was to understand clinician rationale for ordering monitoring lipid panels among patients on statin therapy and to determine how often treatment changes occur as a result of testing. For their bottom line, Joe and Andrew conclude that most monitoring of lipid profiles did not result in a change in therapy so just stop doing it.